CAMBRIDGE, England & SAN ANTONIO--(BUSINESS WIRE)--SOLASCURE Ltd (“SolasCure”), a biotechnology company developing a novel treatment to transform ...
News
- SolasCure Completes Phase II Clinical Trial, Demonstrating Accelerated Healing ... - Business Wire
- How a prostate cancer drug and a $1.7 billion deal landed at Vir Bio - San Francisco Business Times
Vir Biotechnology secured a $1.7B deal with Astellas Pharma for an ... San Antonio · San Francisco · Seattle · Silicon Valley · St. Louis · Tampa Bay ...
- Immunophotonics Secures European Patent Protecting Use of Lead Asset in Combination ...
SAINT LOUIS, MO, UNITED STATES, February 24, 2026 /EINPresswire.com/ — Immunophotonics, Inc., a clinical-stage biotech ... Houzeo Reveals the 2026's ...
- Houzeo Reveals the 2026's Best Neighborhoods to Live in San Antonio, Texas - The Des ...
This new ranking provides insights into San Antonio's best neighborhoods for homebuyers, focusing on affordability, livability, and key economic ...
- Bakar Labs Helps Companies Raise More Than $1 Billion in Its First Four Years of Operation
... biotech funding sharply declined. Since its official opening in ... Houzeo Reveals the 2026's Best Neighborhoods to Live ...
